Figure 2.
The nexus of catecholamine receptor, G protein, and GPCR kinase: An opportunity for cardiotherapeutic intervention. Schematized
is a molecule of βARK1 (i.e., GRK2), the most abundant cardiac GRK, which is positioned, through the interaction between its
C-terminal domain and the βγ heterodimer (Gβγ) of an activated G protein, so as to phosphorylate a βAR molecule. Phosphorylation
results in cellular desensitization to catecholamines, which may be involved is certain pathological conditions. To prevent
the phosphorylation of the βAR (and thereby preclude desensitization), therapeutic strategies may utilize peptides or small
molecules that interfere with the interaction between GRKs and the Gβγ heterodimer.